Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

NCT01348737 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Safety
Tolerability
Blood Concentration
Healthy Volunteers

Interventions

DRUG: AZD3839
DRUG: AZD3839 Placebo

Sponsor

AstraZeneca